|
Abstract:Introduction: To assess the impact of delayed surgery on the prognosis of
patients with operable stage non-small cell lung cancer (NSCLC).
Methods: A retrospective review of 140 patients with clinical operable stage
NSCLC (I, II, IIIA) who underwent curative surgery was conducted. Patients were
divided into two groups: those who underwent surgery within 3 months of initial lung
tumor detection (non-delayed group, n=82) and those with surgery beyond 3 months
(delayed group, n=58). Patient characteristics, reasons for surgical delay, pathology,
surgical outcomes, and long-term survival were analyzed.
Results: The median time from lung tumor detection to surgery was 13.7 months
(range, 3.1 months-12.1 years) in delayed group, and 0.9 months (range, 3 days-2.8
months) in non-delayed group (P<0.001). The delayed group had a higher
proportion of patients at clinical stages I and II, and a lower proportion at clinical
stage IIIA as compared with non-delayed group (P=0.046). The incidence of
lymphovascular invasion was significantly lower in delayed group (P=0.031). There
was no significant difference between groups in terms of pathological upstaging,
positive surgical margins, surgical morbidity and mortality, adjuvant treatment,
disease-free survival, and overall survival.
Conclusions: The prognosis for patients with delayed diagnosis or surgery for
NSCLC may not necessarily be worse than for those who receive timely surgery. For these patients, in spite of previous delay, surgical resection remains an important
treatment option if lung cancer is assessed as an operable stage disease
preoperatively. |
|
Authors:Yueh-Feng Tsai, Meng-Ping Dai, Wen-Pin Wu, Chien-Chih Ou, Shih-Chuan Hsiao, Mao-Te Chuang, Chiung-Lun Kao, Chung-Jing Wang |